LIFE

aTyr Pharma Inc.

Price

$36.72

return (12m)

p/e

-18.02

p/bv

4.86

DIVIDEND YIELD

0.00%

LIFE price

aTyr Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LIFE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

88.60%

3 months

73.70%

1 year

0.00%

2 years

0.00%

5 years

590.23%

10 years

-9.56%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LIFE

Valuation

P/E

-18.02

Sector -4.32

Industry -4.32

P/BV

4.86

Sector 2.14

Industry 2.14

P/Revenue (PSR)

4.91

Sector 2.10

Industry 2.10

EV/EBITDA

Sector -205.63

Industry -205.63

EV/EBIT

Sector -44.80

Industry -44.80

P/EBITDA

Sector -20.37

Industry -20.37

P/EBIT

Sector -30.67

Industry -30.67

P/Total Assets

3.32

Sector 1.28

Industry 1.28

P/Net Current Assets

28.18

Sector -11.26

Industry -11.26

P/Working Capital

22.47

Sector -1.28

Industry -1.28

EPS

-2.04

Sector -2.01

Industry -2.01

BVPS

7.56

Sector 1.94

Industry 1.94

Efficiency

Gross Margin

98.16%

Sector 37.97%

Industry 37.97%

EBITDA Margin

0.00%

Sector -16,590.01%

Industry -16,590.01%

EBIT Margin

0.00%

Sector -4,202,867.70%

Industry -4,202,867.70%

Operating Margin

-26.80%

Sector -37.03%

Industry -37.03%

Net Profit Margins

-27.23%

Sector -38.20%

Industry -38.20%

Asset Turnover

0.27

Sector 0.03

Industry 0.03

Profitability

ROE

-26.96%

Sector -62.10%

Industry -62.10%

ROA

-18.44%

Sector -64.73%

Industry -64.73%

ROIC

0.00%

Sector -1,826.60%

Industry -1,826.60%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.52

Sector 2.92

Industry 2.92

Net Debt / EBITDA

Sector -13,814,519.62

Industry -13,814,519.62

Net Debt / EBIT

Sector -3.00

Industry -3.00

Net Debt / Equity

0.00

Sector -1.09

Industry -1.09

Gross Debt / Equity

0.00

Sector 0.00

Industry 0.00

Equity/Assets

0.68

Sector 0.43

Industry 0.43

Liabilities/Assets

0.32

Sector 0.40

Industry 0.40

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals LIFE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LIFE aTyr Pharma Inc.	$36.72	-	0.00%	-18.02	4.86	-26.96%	-27.23%
JNJ Johnson & Johnson	$273.14	56.94%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$28.57	20.21%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$265.76	30.22%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.92	-11.58%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$150.66	79.15%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$169.66	9.08%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.92	48.46%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$77.29	-49.54%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$828.50	45.54%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$442.24	55.97%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$109.32	52.21%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$873.79	27.39%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$552.85	39.92%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$232.37	58.91%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$38.50	1.69%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$220.77	58.47%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LIFE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT aTyr Pharma

aTyr Pharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

21 years

Founded: 2005

Time since IPO - - year

44

Employees

aTyr Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.31 billion, with shareholders equity totaling $476.17 million.

The company employs approximately 44 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, aTyr Pharma Inc. reported $471.51 million in revenue, generating net income of $-128.39 million.

Key financial metrics include a P/E ratio of -18.02, a price-to-book (P/B) ratio of 4.86, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LIFE.

Market cap

$2.31 billion

Net worth

$476.17 million

$476,170,000.00

Assets

$696.08 million

$696,080,000.00

Total Shares Outstanding

63.00 million

63,000,000

Average Daily Trading Volume

$967.64 Thousand

$967,639.30

Sector

Health Care

Industry

Biotechnology

LIFE

LIFE revenue and profits

Financial Results LIFE

DRAG THE FRAME TO SEE MORE DATA

LIFE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$873.79 29,23% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$232.37 60,79% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$273.14 57,72% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$265.76 32,13% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$150.66 82,46% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$169.66 8,71% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$28.57 23,75% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$873.79 29,23% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$232.37 60,79% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$273.14 57,72% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$265.76 32,13% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$150.66 82,46% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$169.66 8,71% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$28.57 23,75% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of aTyr Pharma (LIFE) today?

A cotação de aTyr Pharma (LIFE) hoje está em US$ 36.72, com uma variação de 0% em relação ao último ano. A cotação de aTyr Pharma (LIFE) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 36.72. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de aTyr Pharma (LIFE) e dados de ações do Ibovespa e mercados internacionais.

Quando aTyr Pharma (LIFE) paga dividendos?

aTyr Pharma (LIFE) não distribuiu dividendos no último ano.

Is aTyr Pharma (LIFE) a good investment?

Atualmente, aTyr Pharma (LIFE) está cotada a US$ 36.72, com um P/L de -18.02, representando um desvio de -901% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy aTyr Pharma (LIFE) stock?

Investir em ações de aTyr Pharma (LIFE) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of aTyr Pharma (LIFE) yield today?

A rentabilidade de aTyr Pharma (LIFE) foi de 88.60% no último mês, 0.00% no último ano e 590.23% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de aTyr Pharma (LIFE) hoje, o investimento total seria de US$ 3,672.00, com base na cotação atual de US$ 36.72.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 3,672.00
Em 5 anos: US$ 25,345.25
Em 10 anos: US$ 3,320.96

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LIFE

aTyr Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LIFE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LIFE WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT aTyr Pharma

aTyr Pharma Inc.

United States

21 years

44

Financial Results LIFE

LIFE cash flow

Asset, Revenue and Profit Growth - LIFE

LIFE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions